BIOMAT Database Logo BIOMAT Database Logo

[Effect of sulfonamides on enzyme systems; effect on invasion factor (hyaluronidase)]. 1951

V PRAZAK

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006821 Hyaluronoglucosaminidase An enzyme that catalyzes the random hydrolysis of 1,4-linkages between N-acetyl-beta-D-glucosamine and D-glucuronate residues in hyaluronate. (From Enzyme Nomenclature, 1992) There has been use as ANTINEOPLASTIC AGENTS to limit NEOPLASM METASTASIS. Hyaluronidase,Duran-Reynals Permeability Factor,GL Enzyme,Hyaglosidase,Hyaluronate Hydrolase,Wydase,Duran Reynals Permeability Factor,Factor, Duran-Reynals Permeability,Hydrolase, Hyaluronate,Permeability Factor, Duran-Reynals
D000077145 Sulfanilamide A short-acting sulfonamide used as an anti-infective agent. It has lower anti-bacterial activity than SULFAMETHOXAZOLE. 4-aminobenzenesulfonamide,Azol Polvo,Sulfanilamide Barium Salt,Sulfanilamide Cadmium Salt,Sulfanilamide Hydrochloride,Sulfanilamide Lithium Salt,Sulfanilamide Magnesium Salt,Sulfanilamide Monohydrate,Sulfanilamide Silver Salt,Sulfanilamide Sodium,Sulfanilamide Sodium Salt,Sulfanilamide Strontium Salt,Sulfanilamide Zinc Salt,Sulphanilamide,4 aminobenzenesulfonamide
D013424 Sulfanilamides Compounds based on 4-aminobenzenesulfonamide. The '-anil-' part of the name refers to aniline. Sulphanilamides
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide

Related Publications

V PRAZAK
Mucolytic enzyme systems. XIV. Effect of certain quinolines on hyaluronidase and its serum inhibitor.
August 1950, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
V PRAZAK
[Action of hypoglycemic sulfonamides on various enzyme systems in vitro].
September 1960, Annales pharmaceutiques francaises,
V PRAZAK
Mucolytic enzyme systems XIII; effect of compounds on hyaluronidase and its inhibition by human serum.
June 1950, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
V PRAZAK
[Comparative studies on the effect of hyaluronidase on the absorption of sulfonamides from the respiratory tract].
March 1955, Arztliche Forschung,
V PRAZAK
Effect of hyaluronidase (GL enzyme) on mortality after myocardial infarction.
June 1982, Lancet (London, England),
V PRAZAK
Mucolytic enzyme systems; nonspecific hyaluronidase inhibitor in rheumatic fever.
January 1950, The Journal of infectious diseases,
V PRAZAK
Mucolytic enzyme systems; inhibition of hyaluronidase oy serum in poliomyelitis.
January 1948, The Journal of infectious diseases,
V PRAZAK
Mucolytic enzyme systems. X. Serum hyaluronidase inhibitor in liver disease.
August 1950, The Journal of clinical investigation,
V PRAZAK
Mucolytic enzyme systems; inhibition of hyaluronidase by serum in human cancer.
December 1948, Journal of the National Cancer Institute,
V PRAZAK
Mucolytic enzyme systems; inhibition of hyaluronidase by serum in skin diseases.
October 1948, The Journal of investigative dermatology,
Copied contents to your clipboard!